Immediate Impact
1 by Nobel laureates 6 from Science/Nature 67 standout
Citing Papers
Trial of a Preferential Phosphodiesterase 4B Inhibitor for Idiopathic Pulmonary Fibrosis
2022 Standout
Psoriasis
2021 Standout
Works of Richard Shames being referenced
Tildrakizumab (MK-3222), an anti-interleukin-23p19 monoclonal antibody, improves psoriasis in a phase IIb randomized placebo-controlled trial
2015
Daclizumab, a humanised monoclonal antibody to the interleukin 2 receptor (CD25), for the treatment of moderately to severely active ulcerative colitis: a randomised, double blind, placebo controlled, dose ranging trial
2006
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Richard Shames | 338 | 358 | 75 | 172 | 19 | 881 | |
| Reuben Falkoff | 203 | 572 | 51 | 66 | 16 | 1.2k | |
| Ellen Sher | 619 | 324 | 91 | 56 | 15 | 1.0k | |
| Denise Daley | 326 | 135 | 165 | 55 | 37 | 935 | |
| Matteo Borro | 258 | 174 | 112 | 74 | 22 | 747 | |
| Karin Söderberg | 149 | 107 | 205 | 77 | 33 | 1.1k | |
| Danielle Baum | 139 | 390 | 49 | 280 | 14 | 764 | |
| Gertrude M. Möller | 348 | 223 | 235 | 52 | 15 | 868 | |
| Stefan Ivanov | 582 | 278 | 41 | 58 | 21 | 994 | |
| G. F. Ryan | 736 | 243 | 74 | 63 | 11 | 1.0k | |
| Michiel W. van der Linden | 115 | 378 | 108 | 44 | 33 | 992 |
All Works
Loading papers...